198 related articles for article (PubMed ID: 12518184)
1. Combination therapy as first-line treatment of arterial hypertension.
Ruzicka M; Leenen FH
Can J Cardiol; 2002 Dec; 18(12):1317-27. PubMed ID: 12518184
[TBL] [Abstract][Full Text] [Related]
2. Monotherapy versus combination therapy as first line treatment of uncomplicated arterial hypertension.
Ruzicka M; Leenen FH
Drugs; 2001; 61(7):943-54. PubMed ID: 11434450
[TBL] [Abstract][Full Text] [Related]
3. Low-dose fixed combination of bisoprolol/hydrochlorothiazide as first line for hypertension: a review of the rationale and clinical evidence.
Papadopoulos DP; Papademetriou V
Angiology; 2009; 60(5):601-7. PubMed ID: 19028769
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
Rosei EA; Rizzoni D;
J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
[TBL] [Abstract][Full Text] [Related]
6. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
7. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
Lindholm LH; Persson M; Alaupovic P; Carlberg B; Svensson A; Samuelsson O
J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
[TBL] [Abstract][Full Text] [Related]
8. Fixed low-dose combination in first-line treatment of hypertension.
Prisant LM
J Hypertens Suppl; 2002 Feb; 20(1):S11-9. PubMed ID: 11996195
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
Lacourcière Y; Poirier L; Hebert D; Assouline L; Stolt P; Rehel B; Khder Y
Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
[TBL] [Abstract][Full Text] [Related]
10. [Fixed-dose combinations in the first line of antihypertensive therapy].
Urbán L; Mészáros A
Acta Pharm Hung; 2007; 77(3):180-4. PubMed ID: 18019783
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.
Abe M; Okada K; Matsumoto K
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1285-303. PubMed ID: 19761411
[TBL] [Abstract][Full Text] [Related]
12. Issues in blood pressure control and the potential role of single-pill combination therapies.
Burnier M; Brown RE; Ong SH; Keskinaslan A; Khan ZM
Int J Clin Pract; 2009 May; 63(5):790-8. PubMed ID: 19220523
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
Calhoun DA; Glazer RD; Pettyjohn FS; Coenen PD; Zhao Y; Grosso A
Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
[TBL] [Abstract][Full Text] [Related]
14. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy.
Epstein M; Bakris G
Arch Intern Med; 1996 Sep; 156(17):1969-78. PubMed ID: 8823150
[TBL] [Abstract][Full Text] [Related]
15. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[TBL] [Abstract][Full Text] [Related]
16. Combined therapy in the treatment of hypertension.
Escobar C; Barrios V
Fundam Clin Pharmacol; 2010 Feb; 24(1):3-8. PubMed ID: 19682088
[TBL] [Abstract][Full Text] [Related]
17. Healthcare benefits of very-low-dose combination treatment used in the management of hypertension.
Ambrosioni E
J Hypertens Suppl; 2001 Nov; 19(4):S29-36. PubMed ID: 11848260
[TBL] [Abstract][Full Text] [Related]
18. Comparison of low-dose captopril and propranolol as second-line drugs in mild and moderate hypertension.
Traub YM; Rosenfeld JB
Isr J Med Sci; 1985 Sep; 21(9):737-41. PubMed ID: 3902720
[TBL] [Abstract][Full Text] [Related]
19. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
[TBL] [Abstract][Full Text] [Related]
20. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
